Cargando…
Synthesis of Multiple Bispecific Antibody Formats with Only One Single Enzyme Based on Enhanced Trypsiligase †
Bispecific antibodies (bsAbs) were first developed in the 1960s and are now emerging as a leading class of immunotherapies for cancer treatment with the potential to further improve clinical efficacy and safety. Many different formats of bsAbs have been established in the last few years, mainly gene...
Autores principales: | Voigt, Johanna, Meyer, Christoph, Bordusa, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952323/ https://www.ncbi.nlm.nih.gov/pubmed/35328563 http://dx.doi.org/10.3390/ijms23063144 |
Ejemplares similares
-
Trypsiligase‐Catalyzed Labeling of Proteins on Living Cells
por: Liebscher, Sandra, et al.
Publicado: (2021) -
Backbone and nearly complete side-chain chemical shift assignments of the human death-associated protein 1 (DAP1)
por: Wiedemann, Christoph, et al.
Publicado: (2020) -
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
por: Dalla Palma, Benedetta, et al.
Publicado: (2020) -
Bispecific antibodies for non-Hodgkin’s lymphomas and multiple myeloma
por: Castaneda-Puglianini, Omar, et al.
Publicado: (2021) -
Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)